2025 Silent Capital Report now available. Where family offices and LPs are actually deploying. [Download for free →]
About usSign in
Status
ACTIVE
Global HQ
Athens, Greece
Countries of investment
    Investment stages
    • Pre-Seed
    • Seed
    • Series A
    Industries
    • Women's Health
    • Femtech
    • Digital Health
    • Biotech
    • Diagnostics
    • Therapeutics
    • Medical Devices
    • Artificial Intelligence
    • Longevity
    • Mental Health
    About
    WHIF is an Athens-based venture capital fund focused on backing women's health innovation originating in Southern Europe and scaling globally. Their focus spans femtech, diagnostics, therapeutics, digital health, and AI applied to female-specific conditions across Greece, Spain, Portugal, Italy, France, and the wider European Union. Founded by Areti Kalogerogianni and pre-launched in 2025, the firm supports women's health founders from pre-seed through Series A.
    Min check size
    $100K
    Max check size
    $1M
    Fund size
    NPS

    Investment Thesis

    WHIF is a pre-seed to Series A venture capital fund deploying a €50M vehicle exclusively across women's health, femtech, biotech, digital health, and AI-enabled care. They invest in evidence-based solutions spanning the full female lifespan, from reproductive care and pregnancy through menopause, chronic conditions, mental health, and longevity. The firm differentiates itself as Europe's first fund dedicated solely to women's health, with a Southern Europe sourcing advantage built on regional scientific talent and untapped markets.
    Lead investor
    Co Invest
    Number of exits
    Preferred contact method

    Team

    Areti Kalogerogianni-Founder & Managing Partner

    Fund number
    Year Founded
    Vintage Year
    Net Internal Rate of Return
    Investment Multiple
    Capital Allocation
    Management Fee
    Carried Interest
    AUM
    Follow-on Investments
    Graduation Rate
    Write-Off Ratio
    Last profile update timestamp